Human malignancies arise predominantly in tissues of epithelial origin, where the stepwise
transformation from healthy epithelium to premalignant dysplasia to invasive neoplasia …

Update on Keratinocyte Carcinomas | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

To define the cellular composition and architecture of cutaneous squamous cell carcinoma
(cSCC), we combined single-cell RNA sequencing with spatial transcriptomics and …

PURPOSE Treatment options are limited for patients with recurrent and/or metastatic (R/M)
cutaneous squamous cell carcinoma (cSCC); mortality rates exceed 70% in patients with …

In order to update recommendations on treatment, supportive care, education and follow-up
of patients with invasive cutaneous squamous cell carcinoma (cSCC), a multidisciplinary …

Cutaneous squamous cell carcinoma (cSCC) is the second most common form of human
cancer and has an increasing annual incidence. Although most cSCC is cured with office …

Background Cemiplimab has shown substantial antitumour activity in patients with
metastatic cutaneous squamous cell carcinoma. Patients with locally advanced cutaneous …

Cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in
Caucasian populations, accounting for 20% of all cutaneous malignancies. A unique …

PURPOSE To evaluate first-line pembrolizumab monotherapy efficacy and safety in patients
with unresectable cutaneous squamous cell carcinomas (CSCCs). PATIENTS AND …

Non-melanoma skin cancer represents one-third of all malignancies and its incidence is
expected to rise until the year 2040. Cutaneous squamous cell carcinoma (cSCC) …